Maze Therapeutics' Chief Medical Officer Sold 100% of His Direct Holdings. Here's What This Means for Investors.

Chief Medical Officer Harold Bernstein sold 15,000 shares on April 1, 2026 for approximately $442,000, at about $29.46 per share. The disposition represented 100% of his direct common stock holdings, reducing his direct ownership to zero; this is factual insider-sale news that may raise investor questions but provides no company-operational information.

Analysis

Chief Medical Officer Harold Bernstein sold 15,000 shares on April 1, 2026 for approximately $442,000, at about $29.46 per share. The disposition represented 100% of his direct common stock holdings, reducing his direct ownership to zero; this is factual insider-sale news that may raise investor questions but provides no company-operational information.